Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants
Journal article
Johnson M. et al, (2024), The Journal of Infectious Diseases, 229, S112 - S119
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection.
Journal article
Chappin K. et al, (2024), The Journal of infectious diseases, 229, S100 - S111
Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections During Pregnancy.
Journal article
Kenmoe S. et al, (2024), The Journal of infectious diseases, 229, S51 - S60
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study
Journal article
Browne AJ. et al, (2024), The Lancet Global Health, 12, e406 - e418
Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study.
Journal article
Ashton PM. et al, (2024), The Lancet. Microbe, 5, e226 - e234
Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis.
Journal article
Deng S. et al, (2024), The Journal of infectious diseases, 229, S25 - S33
Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.
Journal article
Osei-Yeboah R. et al, (2024), The Journal of infectious diseases, 229, S61 - S69
Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.
Journal article
Osei-Yeboah R. et al, (2024), The Journal of infectious diseases, 229, S70 - S77
Respiratory Syncytial Virus European Laboratory Network 2022 Survey: Need for Harmonization and Enhanced Molecular Surveillance.
Conference paper
Presser LD. et al, (2024), The Journal of infectious diseases, 229, S34 - S39
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus.
Journal article
Lin G-L. et al, (2024), Nature communications, 15
Underreporting and Misclassification of Respiratory Syncytial Virus-Coded Hospitalization Among Adults in Denmark Between 2015-2016 and 2017-2018.
Journal article
Egeskov-Cavling AM. et al, (2024), The Journal of infectious diseases, 229, S78 - S83
Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review.
Journal article
Sheikh Z. et al, (2024), The Journal of infectious diseases, 229, S8 - S17
Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
Preprint
Williams LR. et al, (2024)
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study
Journal article
Puri A. et al, (2024), Vaccines, 12, 210 - 210
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study.
Journal article
Meeraus W. et al, (2024), The Journal of infection
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.
Journal article
Bijukchhe SM. et al, (2024), Vaccine
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Journal article
Antimicrobial Resistance Collaborators None., (2024), The Lancet. Global health, 12, e201 - e216
Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK.
Journal article
Smith C. et al, (2024), BMJ Open, 14
Spotlight on systems vaccinology: a novel approach to elucidate correlates of protection.
Journal article
Zhu H. et al, (2023), Genes Immun